SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-14-024468
Filing Date
2014-01-28
Accepted
2014-01-28 17:01:18
Documents
3
Effectiveness Date
2014-01-28

Document Format Files

Seq Description Document Type Size
1 S-8 d665306ds8.htm S-8 54430
2 EX-5.1 d665306dex51.htm EX-5.1 4131
3 EX-23.2 d665306dex232.htm EX-23.2 1556
  Complete submission text file 0001193125-14-024468.txt   61146
Mailing Address 2200 PENNSYLVANIA AVE NW SUITE 300E WASHINGTON DC 20037
Business Address 2200 PENNSYLVANIA AVE NW SUITE 300E WASHINGTON DC 20037 202-734-3400
Vanda Pharmaceuticals Inc. (Filer) CIK: 0001347178 (see all company filings)

IRS No.: 030491827 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-193614 | Film No.: 14553697
SIC: 2834 Pharmaceutical Preparations